In an osteoarthritic knee, inflammatory cytokines (“bad” proteins) outnumber anti-inflammatory cytokines (“good” proteins) causing an imbalance resulting in knee pain and cartilage degeneration.11
The inflammatory proteins IL-1 and TNFa attack the cartilage11 These “bad” proteins must be stopped simultaneously to decrease pain and slow cartilage degeneration.
The nSTRIDE® treatment introduces high levels of “good” proteins (IL-1ra, sIL-1R, sTNF-RI, and sTNF-RII)10 that is designed to overwhelm and block the inflammatory cytokines (bad proteins) IL-1 and TNFa.15^ Laboratory, animal and human studies have shown that nSTRIDE® has decreased pain and slowed cartilage degeneration, unlike traditional therapies.3^,4,14
While balance is being restored to the knee, anabolic (building) growth factors (IGF-1 and TGF-.1) are also introduced for beneficial cartilage health.10 Therefore, nSTRIDE® creates a novel therapy, which may reduce pain in the knee joint, may improve joint function and slow the destruction of cartilage.4^
This Autologous Anti-Inflammatory treatment is provided in a single session in the doctor’s office.